Another Top Pfizer Exec Resigns!

What’s happening in Pfizer’s Company?

Join Our Telegram channel here:

It seems that they have long-term executives leaving the company, and maybe they cashed in on their stock options that surged to unprecedented levels throughout this in-purpose created pandemic.

Also, maybe they aren’t feeling comfortable with their position in the company and the entire situation they have caused.

Perhaps that is why they bold them from the scene when confronted with reports. We have seen many people running from the press and hiding their faces, but bold? The only honor belongs to only one Pfizer executive.

He’s CFO Frank D’Amelio. He made headlines today with his retirement. Pfizer now looks for another CFO to take the seasoned executive’s place.

Check this out.

The Wall Street Journal reported:

Mr. D’Amelio also serves as Pfizer’s executive vice president of global supply. In connection with Mr. D’Amelio’s planned retirement, Pfizer named Mike McDermott as chief global supply officer, effective Jan. 1. Mr. McDermott, who is currently president of global supply, will join Pfizer’s leadership team and report to Chief Executive Albert Bourla.

The finance chief’s retirement comes as Pfizer ramps up production of its Covid-19 vaccine.

Business Wire also covered this story :

“I want to thank Frank for his many years of service to Pfizer as CFO and for the impact he has had on the Company and the patients we serve,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer.

“Frank has driven a strategic vision for the Company’s financial success, and he leaves Pfizer in a strong position for future growth having been instrumental in our multi-year transformation to an industry leading, science-based biopharmaceutical company.”

Join Our Telegram channel here:


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker